Wockhardt share price has zoomed 5% and is presently trading at Rs 1,096.9.
Meanwhile, the BSE HEALTHCARE index is at 44,760.8 (up 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.1%) and J.B.Chemicals (up 1.8%).
ASTRAZENECA PHARMA (down 1.5%) and SUVEN PHARMACEUTICALS (down 0.9%) are among the top losers today.
Over the last one year, Wockhardt has moved up from Rs 232.3 to Rs 1,096.9, registering a gain of Rs 864.6 (up 372.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,152.0 to 44,760.8, registering a gain of 59.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 176.2%), Glenmark Pharma (up 132.7%) and SUVEN PHARMACEUTICALS (up 107.8%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 82,207.1 (up 0.3%).
The top gainers among the BSE Sensex today are Asian Paints (up 1.4%) and Bharti Airtel (up 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..
In the meantime, NSE Nifty is at 25,198.5 (up 0.3%). Asian Paints and BPCL are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,473.1 to 82,207.1, registering a gain of 15,734.0 points (up 23.7%).
Wockhardt net profit grew 88.2% YoY to Rs -160 million for the quarter ended June 2024, compared to a loss of Rs 1,360 million a year ago. Net sales rose 14.8% to Rs 7,390 million during the period as against Rs 6,440 million in April-June 2023.
For the year ended March 2024, Wockhardt reported 24.0% increase in net profit to Rs -4,720 million compared to net loss of Rs 6,210 million during FY23. Revenue of the company grew 5.5% to Rs 27,980 million during FY24.
The current Price to earnings ratio of Wockhardt, based on rolling 12 month earnings, stands at -47.8.
Equitymaster requests your view! Post a comment on "Wockhardt Gains 5%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!